Clinical implications of routine genomic mutation sequencing in PIK3CA/AKT1 and KRAS/NRAS/BRAF in metastatic breast cancer
Crossref DOI link: https://doi.org/10.1007/s10549-016-3980-z
Published Online: 2016-09-14
Published Print: 2016-11
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Cejalvo, Juan Miguel
Pérez-Fidalgo, J. Alejandro
Ribas, Gloria
Burgués, Octavio
Mongort, Cristina
Alonso, Elisa
Ibarrola-Villava, Maider
Bermejo, Begoña
Martínez, María Teresa
Cervantes, Andrés
Lluch, Ana
License valid from 2016-09-14